Mesenchymal Stromal Cells A Novel Treatment Modality for Tissue Repair

被引:224
作者
Bernardo, Maria Ester [2 ]
Locatelli, Franco [2 ]
Fibbe, Willem E. [1 ]
机构
[1] Leiden Univ, Med Ctr, Ctr Stem Cell Therapy, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Univ Pavia, Policlin San Matteo, Fdn IRCCS, I-27100 Pavia, Italy
来源
HEMATOPOIETIC STEM CELLS VII | 2009年 / 1176卷
关键词
mesenchymal stem cells (MSCs); cell therapy; autoimmunity; HUMAN-BONE-MARROW; VERSUS-HOST-DISEASE; HEMATOPOIETIC STEM-CELLS; PROLIFERATION IN-VITRO; PROGENITOR CELLS; CORD BLOOD; IMMUNOSUPPRESSIVE PROPERTIES; CLINICAL-APPLICATIONS; EXPERIMENTAL COLITIS; HEALTHY DONORS;
D O I
10.1111/j.1749-6632.2009.04607.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mesenchymal stromal cells (MSCs) are multipotent cells that can be isolated from several human-tissues and expanded ex vivo for clinical use. MSCs are identified by their adherent properties, immunephenotype, and differentiation potential. MSCs display immunological properties that have been demonstrated both in vitro and in vivo, in animal models and in humans, although the exact mechanisms underlying these effects remain largely unknown. MSCs preferentially home to damaged tissue and secrete paracrine factors with anti-inflammatory properties. The immunomodulatory and reparative and anti-inflammatory properties of MSCs have been tested in a variety of animal models and have been applied in specific clinical settings. Potential clinical applications of MSCs include prevention and treatment of therapy-resistant acute graft-versus-host disease, prevention and treatment of rejection after either hematopoieitc stem cell and solid organ transplantation, tissue repair, and treatment of inborn errors and autoimmune diseases. This review focuses on recent advances that have broadened our understanding of the biological and functional properties of MSCs, which are increasingly attracting the attention of researchers involved in the optimization of approaches for reparative and regenerative cell therapy, as well as in the perspective of modulating immune response against alloantigens or, even, autoantigens.
引用
收藏
页码:101 / 117
页数:17
相关论文
共 132 条
  • [11] Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute
    Bernardo, M. E.
    Avanzini, M. A.
    Perotti, C.
    Cometa, A. M.
    Moretta, A.
    Lenta, E.
    Del Fante, C.
    Novara, F.
    De Silvestri, A.
    Amendola, G.
    Zuffardi, O.
    Maccario, R.
    Locatelli, F.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (01) : 121 - 130
  • [12] Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term In vitro culture and do not exhibit telomere maintenance mechanisms
    Bernardo, Maria Ester
    Zaffaroni, Nadia
    Novara, Francesca
    Cometa, Angela Maria
    Avanzini, Maria Antonietta
    Moretta, Antonia
    Montagna, Daniela
    Maccario, Rita
    Villa, Raffaella
    Daidone, Maria Grazia
    Zuffardi, Orsetta
    Locatelli, Franco
    [J]. CANCER RESEARCH, 2007, 67 (19) : 9142 - 9149
  • [13] Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood
    Bieback, K
    Kern, S
    Klüter, H
    Eichler, H
    [J]. STEM CELLS, 2004, 22 (04) : 625 - 634
  • [14] Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
    Bocelli-Tyndall, C.
    Bracci, L.
    Spagnoli, G.
    Braccini, A.
    Bouchenaki, M.
    Ceredig, R.
    Pistoia, V.
    Martin, I.
    Tyndall, A.
    [J]. RHEUMATOLOGY, 2007, 46 (03) : 403 - 408
  • [15] Potential risks of bone marrow cell transplantation into infarcted hearts
    Breitbach, Martin
    Bostani, Toktam
    Roell, Wilhelm
    Xia, Ying
    Dewald, Oliver
    Nygren, Jens M.
    Fries, Jochen W. U.
    Tiemann, Klaus
    Bohlen, Heribert
    Hescheler, Juergen
    Welz, Armin
    Bloch, Wilhelm
    Jacobsen, Sten Eirik W.
    Fleischmann, Bernd K.
    [J]. BLOOD, 2007, 110 (04) : 1362 - 1369
  • [16] Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon
    Brittan, M
    Hunt, T
    Jeffery, R
    Poulsom, R
    Forbes, SJ
    Hodivala-Dilke, K
    Goldman, J
    Alison, MR
    Wright, NA
    [J]. GUT, 2002, 50 (06) : 752 - 757
  • [17] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [18] 2-F
  • [19] Novel markers for the prospective isolation of human MSC
    Buehring, Hans-Joerg
    Battula, Venkata Lokesh
    Treml, Sabrina
    Schewe, Bernhard
    Kanz, Lothar
    Vogel, Wichard
    [J]. HEMATOPOIETIC STEM CELLS VI, 2007, 1106 : 262 - 271
  • [20] Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
    Campagnoli, C
    Roberts, IAG
    Kumar, S
    Bennett, PR
    Bellantuono, I
    Fisk, NM
    [J]. BLOOD, 2001, 98 (08) : 2396 - 2402